Insider · CIK 0001192707
Michael J Stone
director
Files at RLI (RLI CORP). First filing Dec 16, 2024, latest Dec 16, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $85k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RLI: RLI CORP
RLIOct 9, 2026 · close 55.71
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 13, 2025 | RLI RLI CORP | AGrant or award Restricted Stock Unitderivative | +1,681 | $0.00 | $0 | 1,681 | May 15, 2025 |
| May 2, 2025 | RLI RLI CORP | MOption exercise Common Stock | +1,396 | $0.00 | $0 | 431,441 | May 5, 2025 |
| May 2, 2025 | RLI RLI CORP | JOther Common Stock | +44 | $0.00 | $0 | 431,485 | May 5, 2025 |
| May 2, 2025 | RLI RLI CORP | MOption exercise Restricted Stock Unitderivative | -1,396 | $0.00 | $0 | 0 | May 5, 2025 |
| Dec 12, 2024 | RLI RLI CORP | GGift Common Stock | -200 | $0.00 | $0 | 214,811 | Dec 17, 2024 |
| Dec 13, 2024 | RLI RLI CORP | GGift Common Stock | -300 | $0.00 | $0 | 214,511 | Dec 17, 2024 |
| Dec 12, 2024 | RLI RLI CORP | SOpen-market sale Common Stock | -200 | $169.55 | $34k | 214,811 | Dec 16, 2024 |
| Dec 13, 2024 | RLI RLI CORP | SOpen-market sale Common Stock | -300 | $170.75 | $51k | 214,511 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.